If you are a minority shareholder who has been squeezed out of an Israeli company, you have a statutory exit that many shareholders do not know exists. Section 191 of the Companies Law 5759-1999 lets you petition an Israeli court where a matter among the company's affairs is being conducted in a way that oppresses you, and the court has broad discretion to give whatever directions it sees fit to remove or prevent that oppression, including an order that the other shareholders or the company buy your shares, directions on how the company's affairs are to be run in future, and the consequential changes to the articles. You do not have to wait for permission from the people who pushed you out, and you do not have to prove the company was harmed, only that you were.
Maya Ziv Law acts for shareholders whose stake in an Israeli company, often a privately held tech or family business, has quietly lost its meaning. That includes individuals who put their own savings into a family or partner business here in Israel, founders and employees holding a minority stake, and investors based abroad. The board stops meeting. The dividends stop. Your emails go unanswered while salaries, related-party deals and new share issuances flow to the insiders. Section 191 is the tool built for exactly that situation, and this article explains how it works and what to do.
What Section 191 gives a minority shareholder
Section 191 of the Companies Law 5759-1999 is the central minority-protection provision in Israeli company law. Its wording turns on a single matter among a company's affairs, and it is enough that such a matter has been or is being conducted in a manner that oppresses (the Hebrew term is kipuach) some or all of the shareholders, or that there is a material concern that it will be. A whole course of conduct is not required. On a shareholder's application, the court has broad discretion to give whatever directions it sees fit to remove or prevent the oppression.
Two features make this remedy unusually powerful for a frozen-out investor.
How the court-ordered buyout works
For most squeezed-out shareholders the goal is not to keep fighting inside a company that no longer wants them. It is to get out with their capital. Section 191(a) expressly contemplates a forced purchase, where the court orders one side to buy the other side's shares. The section itself sets no valuation standard and guarantees no price. The value is set in the court's discretion. In practice the court usually appoints an independent valuer to fix that value, and the court retains discretion over the valuation date, which may be the date the claim was filed, the date the oppression occurred, or another date the court considers fair.
One limit deserves particular attention. Where the court directs the company itself to buy the shares, the wording of the section makes that expressly subject to section 301 of the Law. A company's purchase of its own shares counts as a distribution, exactly like a dividend, so it is governed by the capital maintenance rules, including the profit test and the solvency test in section 302. The practical consequence is that in a company with no distributable profits, or where a buyback would endanger its ability to meet its debts, that route is not available as it stands, and the realistic direction is one requiring the majority shareholders to buy the shares out of their own pockets. That difference matters, because it decides who pays.
This remedy has been considered at the highest level. In CA 8712/13 Amir Adler v. Shai Levant (Israeli Supreme Court, 1 September 2015), the Court addressed oppression and separation remedies in closely held, quasi-partnership companies, where a breakdown of trust between the shareholders can itself justify relief, and confirmed the court's broad discretion to order a forced purchase or an inter-shareholder buyout mechanism. In that case the Court favoured a structured buyout auction between the shareholders (an envelope-style sealed-bid auction) as the preferred way to separate the parties where there is no clear oppressor, and it made clear that relief can be refused where the petitioner's own conduct contributed to the breakdown. The case is widely treated by Israeli practitioners as a leading authority on how courts approach oppression and separation in private companies.
How fair value is generally approached
The general approach Israeli courts take in an oppression buyout is to value the minority's shares at their full proportional worth, without applying a minority discount, so the frozen-out investor tends to recover a pro-rata share of the whole company's value rather than a marked-down "minority" price. The firm frames this as the general approach only. Valuation in any given case stays within the court's discretion, is fought over by competing experts, and depends heavily on the facts, so it is never a promised outcome. The design of the remedy is nonetheless restorative, and Israeli courts have generally been reluctant to let wrongdoers benefit from a discount that rewards the very conduct that trapped the minority.
Practical indicators of oppression
There is no closed statutory list of oppressive conduct, which is deliberate. Courts look at the overall fairness of how the controllers have treated the minority, especially in a company that functions like a partnership. The following patterns frequently support a Section 191 claim. None is guaranteed to succeed on its own, and the strength of a case depends on the full picture.
The common thread is unfairness in the distribution of power and value between the controllers and the minority, judged against the legitimate expectations the shareholders had when they went into business together. Section 191 does not grant relief automatically, however. The court can refuse relief, or shape it differently, where the shareholder who came to it contributed to the breakdown, so how you behaved in the dispute matters as much as how the controllers behaved.
The deadline a frozen-out investor cannot ignore
Oppression often unfolds slowly, and investors therefore wait too long. Israel's general civil limitation period is seven years (Prescription Law 5718-1958), running from the day the cause of action accrued, subject to exceptions for fraud, concealment and lack of knowledge. Note also section 15A of that Law, added by the Swords of Iron amendment, under which the period from 7 October 2023 to 6 April 2024 is not counted in the limitation period of a non-real-property claim whose period had not already run out before the amendment came into force in January 2024. A Section 191 claim is not immune to time. If you wait years while a course of conduct continues, you risk arguments that part or all of your claim is time-barred, and you give the controllers more time to entrench, dilute and move value out of reach. Do not wait indefinitely, and take advice while the evidence and the remedy are still live.
Practical steps for a shareholder being squeezed out
Many of these disputes settle once a credible Section 191 petition is on the table, because the controllers face an independent valuation and a court that can reshape the company over their objection. The leverage of the remedy is often as valuable as the remedy itself.
How the firm works on these matters
At Maya Ziv Law the firm advises minority shareholders, whether you are a private individual here in Israel, a founder or employee with a minority stake, a family business, or an investor based abroad, on whether your situation fits within Section 191, what relief is realistically available, and how to position a claim or a negotiated exit. The firm handles domestic disputes over small Israeli companies and cross-border disputes alike. It combines an understanding of how Israeli courts treat oppression in closely held companies with a commercial read on valuation and deal dynamics, so the strategy is built around the outcome you are seeking, whether that is a buyout, a restructuring of the company, or pressure that brings the other side to the table.
A shareholder dispute does not stand on its own. Where the parties are spread across countries, the same commercial analysis that drives a Section 191 claim returns when a foreign judgment has to be enforced in Israel, or when the shareholders' agreement sends the dispute to the enforcement of an international arbitration award in Israel. The firm looks at the right enforcement route alongside the oppression claim, so that the relief you win can be realised in practice.
This article is general information, not legal advice, and every shareholder dispute turns on its own facts.
Last reviewed July 2026.
About the author
Adv. Maya Ziv advises private individuals and businesses, domestic Israeli and international alike, on Israeli corporate and litigation matters. Before practicing law she trained in finance at Baruch College and worked at Citi and Vornado, and she is admitted to the Israel Bar. That finance background informs how she approaches shareholder disputes, valuation and the commercial leverage behind a Section 191 claim.
Frequently asked questions
Can a foreign or overseas shareholder use Section 191
Yes. Section 191 protects shareholders of an Israeli company regardless of where they live. The claim is brought in Israel, generally in the District Court, so you will need Israeli counsel, but your residence or nationality does not bar the remedy.
Do I have to prove the company was harmed
No. A Section 191 petition focuses on prejudice to you as a shareholder, not on damage to the company. That is one of the features that makes it more accessible than a derivative claim for a frozen-out investor.
Will the court force the majority to buy my shares
A court-ordered buyout is one of the remedies the court can grant, and it is the one most squeezed-out investors are seeking. The court has discretion over whether to order it and on what terms, and it generally appoints an independent valuer to set the price, so it is a strong possibility in a meritorious case rather than an automatic result. Note also that the court is not confined to a one-way purchase. In Adler v. Levant the Supreme Court held that where there is no clear oppressor, or where the applicant's own conduct negates the oppression claim, the preferred route is a sealed-bid auction between the parties, at the end of which you may find yourself the buyer rather than the seller. It is worth testing your own ability to buy in advance, not only your expectation of being bought out.
Will I get the full value of my shares or a discounted minority price
The general approach in Israeli oppression buyouts is to value the minority's stake at full proportional value without a minority discount. This is the general approach and not a binding rule. Valuation stays within the court's discretion and is contested case by case, so it is not a guaranteed outcome.
How long do I have to bring a claim
Israel's general civil limitation period is seven years, running from the day the cause of action accrued, with exceptions for matters such as fraud and concealment, and with a special suspension under the Swords of Iron amendment that does not count the period from 7 October 2023 to 6 April 2024. Because oppression can unfold over time, you should take advice early rather than assume you have the full seven years on every part of your claim.
Sources
Primary Israeli legislation underlying this article.